Australian University Rankings Guide

Drug Discovery Today: Therapeutic Strategies (ERA Journal)

Drug Discovery Today: Therapeutic Strategies is an ERA accredited research journal used as part of the evaluation of the ERA research rankings.

Drug Discovery Today: Therapeutic Strategies issn is: 1740-6773.

The fields covered by Drug Discovery Today: Therapeutic Strategies as part of the evaluation of Australian university research excellence are:

Information and Computing Sciences Research Rankings (Major Field)

Technology Research Rankings (Major Field)

Medical and Health Sciences Research Rankings (Major Field)

Other ERA-accredited journals supporting the evaluation of the Information and Computing Sciences field include:

- Computational Statistics
- Digital Creativity
- Digital Humanities Quarterly
- Genetic Programming and Evolvable Machines
- Genomics Proteomics and Bioinformatics
- Information Technology in Industry
- International Journal of Advanced Pervasive and Ubiquitous Computing
- International Journal of Applied Mathematics and Computer Sciences
- International Journal of Computational Biology and Drug Design
- International Journal of Critical Computer-Based Systems
- International Journal of Information and Communication Technology
- International Journal of Medical Informatics
- Internet Research
- Journal of Information Science and Engineering
- Journal of Knowledge Management


ERA Research Rankings Submenu


- ERA 2018 Outcomes Research Rankings List

- ERA 2018 Research Rankings Analysis

- ERA 2018 Individual University Outcomes List

- ERA List of Research Fields Rankings

- ERA Journal Rankings 2018 List



Latest News and Updates:


- Top 10 Best Australian Universities

- Gender Balance Male-Female Ratio

- ERA 2018 Outcomes Research Rankings List

- University Bachelor Degree Completion Rates

- QS Employability Rankings Australian Universities

- ARWU World Rankings of Australian Universities

- Group of Eight (go8) World Rankings

Share This Page

  • Share on Facebook1
  • Share on Twitter2
  • Share on Linkedin3
  • Share on Reddit4